Voglibose for prevention of type 2 diabetes mellitus.
Mühlhauser
Ingrid
I
D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D018450:Disease Progression; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007294:Inositol / Q000031:analogs & derivatives* / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D007294:Inositol; C102817:voglibose